Polymer Excipients Market Size, Share, Opportunities, And Trends By Product Type (Polyvinylpyrrolidone, Polyethylene Glycol, Starch, Micro Crystalline Cellulose (MCC), Ethyl and Methyl Cellulose, Hydroxypropyl Methylcellulose (HPMC), Others), By Application (Binders, Viscosity Modifiers, Coatings, Flavors, Preservatives, Colorants, Sweeteners, Others), And Geography - Forecasts From 2024 To 2029

The polymer excipients market is expected to grow at a CAGR of 4.27% during the forecast period (2024-2029).

The polymer excipients market can be defined as the rapidly developing field of components for pharmaceutical formulations originating from synthetic and natural polymers. The following are some of the excipients that are important in drug delivery systems; they improve the stability and efficacy of pharmaceutical products.

The flexible use of polymer excipients in drug delivery systems includes controlled release formulations, encapsulation, coating of tablets, and conjugation to biologics to improve solubility. They are also employed in the production of pharmaceutical inks, the preparation of colorants and pigments, cosmetics, and advanced wound care items. This is due to the enhanced need for new technologies in drug delivery, the rising incidence of diseases, and strict patient compliance.

• The polymer excipients market is on an upward trend and there are several reasons that have attributed to the above trend. TSWI has identified one of the large growth factors as being the global need for new drug delivery systems. With the increase of advanced therapies in the pharmaceutical industry, so is the requirement for excipients with better performance in stability, bioavailability, and effectiveness of the drugs. Polymer excipients that are involved in the controlled release systems, encapsulation, and conjugation to the biologics are critical to incorporate in creating state-of-the-art drug delivery systems. This need is heightened by the increasing incidence of chronic ailments and the necessity to enhance adherence among patients.
• Another avenue for expanding the firm’s growth is the increasing use of generic medicines globally. The market is witnessing the entry of generics, many of which were earlier solely in the domain of branded drugs due to the expiry of patent protection. As such, excipients are the backbone of generic drugs’ quality, safety, and efficacy. In this regard, polymer excipients are significant formulating components that can enhance the chemical and physical stability and, therefore, the efficacy of the therapeutic agents contained in generic products. It is believed that this trend will persist in future years, and the need for polymer excipients will be even higher, stimulating the polymer excipients market’s growth.

POLYMER EXCIPIENTS MARKET SEGMENT ANALYSIS:

• The Polyvinylpyrrolidone segment will likely be the fastest-growing segment during the forecast period.

Out of all the polymer excipients, the polyvinylpyrrolidone (PVP) segment is predicted to be the fastest-growing segment in the identified market for the duration of the forecast year. This can be attributed to the rise in the usage of PVP in the pharmaceutical industry because of its fairly special uses and characteristics. Povidone, which is identified as PVP, is a synthetic polymer that is regarded as an essential excipient in different types of formulations. Ease of absorption into the body, as well as such qualities as solubility and film-forming properties and the organism’s impermeability – all these make it a popular additive in the industry.

PVP is usually used in the production of tablets, capsules, syrup, sterilization, disinfection, and injection. It functions as a binder, disintegrant, solubilizer, and stabilizer in drug formulations, thus acting as an important adjuvant in improving the stability, bioavailability, and effectiveness of pharmaceuticals.

The need for PVP has risen in recent years due to health complications such as chronic diseases and enhancements of techniques in drug delivery systems. With the progression of the pharmaceutical industry and the creation of more specific, effective medication the need for excipients rises as they play the role of improving drug efficiency. The generalization of patient services and the need for more sophisticated and individualized approaches in the management of chronic disease in the field of cardiovascular therapy allows PVP, which can be adapted to different types of drug formulations, to meet these future needs. The new tendencies, such as the biopharmaceuticals production and the COVID-19 vaccine development, also create demand for PVP. The role of excipients as ingredients in the formulation and manufacturing of such essential drugs has been more emphasized during this pandemic, and as a result, great achievements have been made on the market.

• The Binders segment will likely be the fastest-growing segment during the forecast period.

Based on the above analysis, it can be concluded that the binders segment is likely to grow at the fastest rate in the global polymer excipients market over the forecasting period. This may be related to the rising market size for binders in the pharma, which is used to enhance the physical and chemical characteristics of drug products. Polymer excipients belong to the category of binders and are employed in the preparation of solid dosage forms including tablets and capsules. They assist in conveying elasticity, tensile strength, and a bonded composition to the formulation of the product to stay united and preserve its quality during storage or transport. This means that binders can be employed in solution form or as a powder for direct compaction for that specific formulation of drugs.

The rising usage of binders in the pharmaceutical industry is attributed to the rise in chronic ailments and improved drug delivery methods. The modern pharmaceutical industry is characterized by the production of highly specialized medicines, which require effective excipients to further boost their performance. By enhancing the physical and chemical characteristics of drug formulations, binders can effectively address this increasing demand.

The global trend of biopharmaceuticals and the need for the COVID-19 vaccine have caused increased binders consumption. The COVID-19 crisis has brought focus to excipients used in medicinal formulation and development, catalyzing significant market progress.

• The Asia Pacific region will dominate the polymer excipients market during the forecast period.

The Asia Pacific region is expected to dominate the polymer excipients market during the forecast period, driven by several key factors. The primary reason is the increasing demand for polymer excipients in the continuously developing pharmaceutical market in the Asia Pacific area. From the cases of China and India, there has been a change in slope regarding the abstraction of pharmaceutical products through the production and consumption of the same due to the increased prevalence of chronic diseases, an aging population, and more access to healthcare. As the industry of manufacturing drugs evolves, the use of polymer excipients, which are crucial in drug formulation, also increases.

This region is experiencing high growth in the demand for generics, boosting the polymer excipients market. Today’s generic drug makers depend mostly on excipients to make their products safe and effective for their users. Polymer excipients are well accepted in this large and emerging market because of their advantages in terms of improved stability and bioavailability of generic drugs.

The increasing trend of personalized medications, along with the advances in new drug delivery systems in the Asia Pacific region, have boosted the polymer excipients market. Because of their flexibility in the composition of drug formulations, polymer excipients have good potential for meeting the existing and emerging market needs in this region.

In addition, the growth of the biopharmaceutical sector and the invention of the COVID-19 vaccine in the Asia Pacific region have also increased the application of excipients in manufacturing life-saving medicines. This has helped bring several improvements in the polymer excipients market because producers expand their concerns on research to conform to the ever-growing market. Owing to these factors, the Asia Pacific area leads the polymer excipients market within the forecast period because of the fast-growing pharmaceutical industry, the increasing scope of generics, individualized medications, and the advancement of new drug delivery systems.

Polymer Excipients Market Scope:

 

Report Metric	Details
Growth Rate	CAGR of 4.27% from 2024 to 2029
Study Period	2019 to 2029
Historical Data	2019 to 2022
Base Year	2024
Forecast Period	2024 – 2029
Forecast Unit (Value)	USD Billion
Segments Covered	Product Type Application Geography
Companies Covered	ABITEC ADM Ashland BASF SE Colorcon
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Customization Scope	Free report customization with purchase

 

The polymer excipients market is segmented and analyzed as follows:

• By Product Type
  • Polyvinylpyrrolidone
  • Polyethylene Glycol
  • Starch
  • Micro Crystalline Cellulose (MCC)
  • Ethyl and Methyl Cellulose
  • Hydroxypropyl Methylcellulose (HPMC)
  • Others
• By Application
  • Binders
  • Viscosity Modifiers
  • Coatings
  • Flavors
  • Preservatives
  • Colorants
  • Sweeteners
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Middle East and Africa
    • Saudi Arabia
    • Saudi Arabia
    • United Arab Emirates
    • Rest of the Middle East and Africa
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Rest of Asia-Pacific

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.1.1. Growing Pharmaceutical Industry 

4.1.2. Rising Demand for Polymer Excipients from Coatings Application 

4.2. Market Restraints

4.2.1. Stringent Rules by Regulatory Bodies 

4.2.2.  Concerns to Meet the Required Quality of Product 

4.2.3. Threats from Substitutes

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. The Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. POLYMER EXCIPIENTS MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Polyvinylpyrrolidone 

5.3. Polyethylene Glycol

5.4.  Starch 

5.5.  Micro Crystalline Cellulose (MCC) 

5.6. Ethyl and Methyl Cellulose 

5.7. Hydroxypropyl Methylcellulose (HPMC) 

5.8.  Others 

6. POLYMER EXCIPIENTS MARKET BY APPLICATION

6.1. Introduction

6.2. Binders 

6.3. Viscosity Modifiers 

6.4. Coatings 

6.5. Flavors 

6.6. Preservatives 

6.7. Colorants 

6.8. Sweeteners 

6.9. Others 

7. POLYMER EXCIPIENTS MARKET BY GEOGRAPHY

7.1. Global Overview

7.2. North America

7.2.1. United States

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Rest of South America

7.4. Europe

7.4.1. United Kingdom

7.4.2. Germany

7.4.3. France

7.4.4. Italy

7.4.5. Spain

7.4.6. Rest of Europe

7.5. Middle East and Africa

7.5.1. Saudi Arabia

7.5.2. United Arab Emirates

7.5.3. Rest of Middle East and Africa

7.6. Asia-Pacific

7.6.1. China

7.6.2. India

7.6.3. Japan

7.6.4. South Korea

7.6.5. Taiwan

7.6.6. Thailand

7.6.7. Indonesia

7.6.8. Rest of Asia-Pacific

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. ABITEC 

9.2. ADM 

9.3. Ashland 

9.4. BASF SE 

9.5.  Cargill, Incorporated. 

9.6.  Colorcon 

9.7. Croda International Plc 

9.8.  DFE Pharma 

9.9.  Dow 

9.10. DuPont 

9.11. Eastman Chemical Company 

9.12. Evonik Industries AG 

9.13. FINAR LIMITED 

9.14. JRS PHARMA 

9.15. Kerry Inc. 

9.16. Roquette Frères 

9.17. The Lubrizol Corporation 

ABITEC 

ADM 

Ashland 

BASF SE 

Cargill, Incorporated. 

Colorcon 

Croda International Plc 

DFE Pharma 

Dow 

DuPont 

Eastman Chemical Company 

Evonik Industries AG 

FINAR LIMITED 

JRS PHARMA 

Kerry Inc. 

Roquette Frères 

The Lubrizol Corporation